Company intelligence / Profile preview

Cavidi

Uppsala, Uppsala County, Sweden

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Cavidi is a Swedish biotechnology company specializing in high-sensitivity diagnostic tools for HIV monitoring. The company is best known for its ExaVir Load assay, which measures the activity of the HIV reverse transcriptase enzyme to determine viral load. This technology provides a cost-effective and robust alternative to traditional PCR-based methods, making it particularly suitable for resource-limited settings. Cavidi's products are designed to improve the management of HIV/AIDS by providing accessible viral load testing to ensure effective antiretroviral therapy.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic Assay
Industry: Protein Biomarker Diagnostics

Partnerships

Clinton Health Access InitiativeUNICEFWorld Health Organization

Beyond the preview

Go deeper on Cavidi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cavidi.

Explore the full profile